HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ran Chen Selected Research

Apolipoproteins E (ApoE)

4/2024Quinic acid regulated TMA/TMAO-related lipid metabolism and vascular endothelial function through gut microbiota to inhibit atherosclerotic.
6/2018[Changes of apoE protein expression in lung of mice with hypoxic pulmonary arterial hypertension].
11/2017Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE-/- Mice.
6/2017[Apelin attenuates hypoxia induced pulmonary hypertension of mice through regulation of lipid metabolism].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ran Chen Research Topics

Disease

57Neoplasms (Cancer)
05/2024 - 07/2010
37Infections
05/2024 - 11/2004
18Inflammation (Inflammations)
04/2024 - 02/2010
8Malaria
03/2024 - 11/2019
8Neoplasm Metastasis (Metastasis)
10/2023 - 01/2014
8Hypoxia (Hypoxemia)
01/2023 - 01/2014
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 10/2014
7Squamous Cell Carcinoma of Head and Neck
01/2024 - 01/2020
7Carcinogenesis
10/2023 - 09/2015
6Lung Neoplasms (Lung Cancer)
02/2024 - 09/2016
6Hepatocellular Carcinoma (Hepatoma)
07/2023 - 06/2017
6Prostatic Neoplasms (Prostate Cancer)
10/2022 - 01/2014
5Body Weight (Weight, Body)
10/2023 - 07/2016
5Chronic Hepatitis B
10/2023 - 10/2016
5Autoimmune Diseases (Autoimmune Disease)
01/2023 - 06/2007
4Multiple Myeloma
04/2024 - 07/2010
4Virus Diseases (Viral Diseases)
02/2024 - 12/2015
4Neuroinflammatory Diseases
01/2024 - 02/2010
4Osteoarthritis
12/2022 - 12/2019
3Atherosclerosis
04/2024 - 11/2017
3COVID-19
02/2024 - 12/2021
3Starvation
12/2023 - 08/2017
3Brain Ischemia (Cerebral Ischemia)
11/2023 - 02/2010
3Reinfection
01/2023 - 07/2013
3Asthma (Bronchial Asthma)
11/2021 - 01/2016
3Stomach Neoplasms (Stomach Cancer)
07/2020 - 01/2019
3Vascular Remodeling
01/2020 - 03/2013
3Fibrosis (Cirrhosis)
09/2019 - 11/2017
3Pulmonary Hypertension
06/2018 - 03/2013
3Tuberculosis (Tuberculoses)
01/2018 - 01/2012
2Bacterial Infections (Bacterial Infection)
05/2024 - 01/2012
2Trypanosomiasis
05/2024 - 01/2022
2Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 01/2023
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2024 - 12/2021
2Acute Lung Injury
12/2023 - 04/2017
2Genomic Instability
12/2023 - 01/2018
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2023 - 12/2022
2Hemorrhage
07/2023 - 07/2023
2Liver Diseases (Liver Disease)
07/2023 - 02/2018
2Toxoplasmosis
07/2023 - 01/2021
2Liver Neoplasms (Liver Cancer)
02/2023 - 01/2018
2Cardiomyopathies (Cardiomyopathy)
01/2023 - 09/2019
2Colitis
01/2023 - 01/2016
2Disease Progression
01/2023 - 11/2017
2Fever (Fevers)
01/2023 - 05/2020

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
03/2024 - 03/2013
14MicroRNAs (MicroRNA)IBA
02/2024 - 09/2015
13Biomarkers (Surrogate Marker)IBA
03/2024 - 09/2016
10VaccinesIBA
10/2023 - 10/2014
8Messenger RNA (mRNA)IBA
11/2023 - 02/2017
7DNA (Deoxyribonucleic Acid)IBA
05/2024 - 07/2010
7Antiviral Agents (Antivirals)IBA
10/2023 - 12/2015
7RNA (Ribonucleic Acid)IBA
02/2023 - 10/2016
6LipidsIBA
04/2024 - 12/2015
5LigandsIBA
10/2023 - 01/2020
5LipopolysaccharidesIBA
01/2023 - 04/2017
4Apolipoproteins E (ApoE)IBA
04/2024 - 06/2017
4Small Interfering RNA (siRNA)IBA
01/2024 - 03/2014
4Peptides (Polypeptides)IBA
12/2023 - 02/2014
4Neutralizing AntibodiesIBA
10/2023 - 01/2022
4Long Noncoding RNAIBA
06/2023 - 02/2017
4ErbB Receptors (EGF Receptor)IBA
03/2023 - 01/2017
4Chloroquine (Aralen)FDA LinkGeneric
01/2021 - 01/2014
4AgarIBA
01/2018 - 10/2017
3AntigensIBA
05/2024 - 03/2018
3AntibodiesIBA
05/2024 - 07/2010
3Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024 - 01/2022
3Antineoplastic Agents (Antineoplastics)IBA
01/2024 - 01/2022
3Phosphotransferases (Kinase)IBA
01/2024 - 01/2018
3oxidized low density lipoproteinIBA
03/2023 - 06/2017
3CollagenIBA
01/2023 - 11/2020
3artenimol (dihydroartemisinin)IBA
11/2022 - 01/2020
3InterferonsIBA
11/2022 - 12/2015
3ApolipoproteinsIBA
09/2022 - 10/2010
3EnzymesIBA
01/2022 - 01/2012
3ApelinIBA
06/2017 - 03/2013
2Immunoglobulin G (IgG)IBA
05/2024 - 10/2023
2Immunoglobulins (Immunoglobulin)IBA
05/2024 - 01/2023
2Bortezomib (Velcade)FDA Link
04/2024 - 01/2024
2Proteasome InhibitorsIBA
01/2024 - 11/2023
2InflammasomesIBA
01/2024 - 01/2019
2Malondialdehyde (Propanedial)IBA
12/2023 - 12/2022
2NitrogenIBA
12/2023 - 12/2022
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
12/2023 - 10/2016
2AntioxidantsIBA
11/2023 - 01/2019
2Carbapenems (Carbapenem Antibiotics)IBA
11/2023 - 01/2021
2Replication Protein AIBA
10/2023 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
10/2023 - 11/2019
2Immunoglobulin E (IgE)IBA
10/2023 - 01/2016
2Cisplatin (Platino)FDA LinkGeneric
06/2023 - 01/2020
2Chimeric Antigen ReceptorsIBA
04/2023 - 01/2023
2Tyrosine Kinase InhibitorsIBA
03/2023 - 08/2022
2Immune Checkpoint InhibitorsIBA
01/2023 - 09/2022
26-methyladenineIBA
01/2023 - 01/2018
2NanovaccinesIBA
01/2023 - 01/2022

Therapy/Procedure

24Therapeutics
05/2024 - 07/2010
9Drug Therapy (Chemotherapy)
12/2023 - 06/2013
9Immunotherapy
07/2023 - 10/2014
5Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 01/2020
4Transplantation
04/2019 - 01/2016